In this guide
What is Banaba Leaf?
Banaba is Lagerstroemia speciosa. Leaf tea, aqueous extract, softgel extract, isolated corosolic acid and ellagitannin-rich products are different exposures. Corosolic acid is a marker or constituent, not proof that products are clinically equivalent. [1], [2], [3]
Typical Banaba Leaf Protocols
| Source and question | Preparation | Amount each administration | Daily total | Frequency and duration | Main interpretation |
|---|---|---|---|---|---|
| Hibi 2022 · double-blind crossover · 14 enrolled/13 analyzed | Powdered beverage with corosolic acid versus placebo | 1 mg corosolic acid | 1 mg/day | Once daily for 2 weeks, 2-week washout, then crossover | Glucose iAUC and insulin AUC changed after 75 g OGTT; fasting glucose and several insulin-sensitivity indices were null |
| Judy 2003 · dose-response study · 10 adults with type 2 diabetes | Banaba extract standardized to 1% corosolic acid in hard or soft capsules | 16, 32 or 48 mg extract, equal to 0.16, 0.32 or 0.48 mg corosolic acid | Same as each study-day administration | Sequential study doses with 10-day washouts | Tiny dose-response experiment; formulation and acute design prevent a chronic protocol |
| Stohs 2012 · evidence review | Banaba extracts, corosolic acid and ellagitannins | Varied | Varied | Acute and short studies | Human evidence remained small and product-specific |
- Exact product
- Record species, form, lot and co-ingredients.
- Each administration
- Keep amount, timing and context.
- Real endpoint
- Separate biomarker, symptom and clinical outcome.
What is it commonly used for?
A 2022 randomized double-blind crossover enrolled 14 middle-aged men with impaired fasting glucose; 13 were analyzed after a protocol violation. A powdered beverage supplied corosolic acid 1 mg once daily for two weeks, followed by a two-week washout and crossover. Glucose incremental AUC and insulin AUC changed after a 75 g oral glucose test, while fasting glucose and several insulin-sensitivity indices were null. Corosolic acid is a banaba constituent, so this does not establish a whole-leaf or tea protocol. [1], [2], [1], [2], [3]
One result answers one question
How do forms and labels differ?
Record L. speciosa, leaf-only identity, water or solvent extraction, corosolic-acid standardization, each amount and co-ingredients. Tea strength and whole-leaf grams cannot be converted into a standardized softgel dose. [4], [2], [3]
How should the product be stored?
Follow the finished product’s label, keep it dry in its original container and away from children. Discard an expired, heat-damaged, broken-seal or untraceable product.
What does human research show?
| Question | Best direct evidence | Finding | Boundary |
|---|---|---|---|
| Efficacy | Hibi 2022 · double-blind crossover · 14 enrolled/13 analyzed | Glucose iAUC and insulin AUC changed after 75 g OGTT; fasting glucose and several insulin-sensitivity indices were null | Specific product and population |
| Replication | Limited evidence | No universal effect established | Variable formulations |
| Universal dose? | None | Not established | Rows cannot be combined |
Keep the finished product reviewable
What are the risks and interactions?
Banaba may add to insulin or other glucose-lowering medicines and may also lower blood pressure. Dizziness, low glucose and gastrointestinal symptoms need attention. Pregnancy, breastfeeding, planned surgery, kidney or liver disease and combined glucose or pressure medicines warrant clinical review. [2], [3], [5], [3], [4], [5]
Seek urgent care for breathing difficulty, throat or tongue swelling, faintness, widespread hives, repeated vomiting or suspected overdose.
What is the legal and regulatory status?
In the United States, it is sold as a dietary supplement; FDA does not approve it for safety and effectiveness before sale. In Canada, verify the exact product, NPN and authorized label. Legal sale does not prove efficacy or sport suitability. [6]
When should use stop?
Stop for any allergic reaction, persistent symptom worsening, unexpected laboratory result or doubt about product identity.
What should be monitored?
Keep the exact extract, corosolic-acid specification, administrations, meals, medicines, glucose and blood pressure together. Acute post-meal glucose, HbA1c and medication reduction are distinct endpoints.
What can community experience add?
Reports can compare tea taste, capsule tolerance and meter readings. They cannot identify active exposure or prove durable benefit. No systematic current community sample was assembled.
How do related options compare?
| Option | Main distinction |
|---|---|
| Leaf tea | Variable extraction in water |
| Whole-leaf powder | Unstandardized constituent exposure |
| Corosolic-acid extract | Specific finished-product specification |
Common questions
Does banaba lower HbA1c?
Durable benefit is not established by the tiny studies.
Is corosolic acid the same as banaba tea?
No.
What does an acute glucose change prove?
Only a short surrogate response in that study.
Can it replace diabetes medicine?
No.
Can it affect blood pressure?
Potential additive lowering warrants monitoring.
What should be tracked?
Exact extract, marker content, meals, medicines, glucose, pressure and symptoms.
Glossary
Terms for reading the evidence.
- Endpoint
- A defined result measured in a study.
- Anaphylaxis
- A potentially life-threatening systemic allergic reaction.
- Biomarker
- A biological measure that does not guarantee clinical benefit.
- Standardization
- A measured specification for a product component.
- Cross-reactivity
- Immune recognition of related proteins from different sources.
How this guide was researched
NCBI identities, publication notices, indexed abstracts and available open methods were checked. Null outcomes, mixed products, surrogate endpoints and missing details remain visible.
Research record · checked October 9, 2026
Identity: Crossref verified Hibi et al., Journal of Functional Foods 2022;97:105256, DOI 10.1016/j.jff.2022.105256. NCBI EFetch verified PMID 22095937; no linked correction or retraction appeared.
Methods: the Hibi full text was read for powdered beverage, once-daily 1 mg, two-week periods, two-week washout and 13 analyzed.
Attribution: purified corosolic acid is not presented as whole-leaf banaba or tea evidence.
Explore the sources
Primary human evidence and official context.
Showing 6 sources
- 01
Corosolic acid improves glucose and insulin responses in middle-aged men with impaired fasting glucose ↗
Randomized double-blind placebo-controlled crossover trial
Fourteen enrolled and 13 analyzed; a powdered beverage supplied 1 mg once daily for two weeks per period with a two-week washout. Fasting glucose was null; selected OGTT measures changed.
- 02
Management of Diabetes and Its Complications with Banaba (Lagerstroemia speciosa L.) and Corosolic Acid. ↗
Human and preclinical evidence review
Provides product, dose and washout details for the tiny 1% corosolic-acid dose-response study and distinguishes extract formulations.
- 03
A review of the efficacy and safety of banaba (Lagerstroemia speciosa L.) and corosolic acid. ↗
Narrative evidence review
Summarizes heterogeneous animal, laboratory and small human studies; the human evidence is too limited for a durable treatment protocol.
- 04
Diabetes and Dietary Supplements: What You Need To Know ↗
Official evidence and safety overview
Evidence for most diabetes supplements is limited; combining them with glucose-lowering treatment can cause unwanted effects.
- 05
Low Blood Glucose (Hypoglycemia) ↗
Official patient guidance
Provides symptom, treatment and emergency boundaries for low glucose.
- 06
FDA 101: Dietary Supplements ↗
Official supplement overview
FDA does not approve dietary supplements for safety and effectiveness before sale.
No matching sources
Try a different term or show the full list.
Editorial note
This guide separates composition, biomarker, symptom and clinical outcome. It does not turn a narrow signal into a general promise.